These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16978273)

  • 1. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
    BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
    Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
    Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
    Porter CR; Kim J
    Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
    Latchamsetty KC; Kim J; Porter CR
    J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
    Eastham JA; May R; Robertson JL; Sartor O; Kattan MW
    Urology; 1999 Oct; 54(4):709-13. PubMed ID: 10510933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
    Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
    Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
    Swords K; Wallen EM; Pruthi RS
    Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    Thompson IM; Ankerst DP; Chi C; Goodman PJ; Tangen CM; Lucia MS; Feng Z; Parnes HL; Coltman CA
    J Natl Cancer Inst; 2006 Apr; 98(8):529-34. PubMed ID: 16622122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening between low-income African-American and Caucasian men.
    Fowke JH; Schlundt D; Signorello LB; Ukoli FA; Blot WJ
    Urol Oncol; 2005; 23(5):333-40. PubMed ID: 16144667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patients.
    Porter CR; Latchamsetty KC; Coogan CL; Kim J
    Clin Prostate Cancer; 2005 Jun; 4(1):50-4. PubMed ID: 15992462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.
    Tang P; Sun L; Uhlman MA; Robertson CN; Polascik TJ; Albala DM; Donatucci CF; Moul JW
    Urology; 2010 Nov; 76(5):1058-62. PubMed ID: 20035982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
    Carver BS; Bozeman CB; Simoneaux WJ; Venable DD; Kattan MW; Eastham JA
    J Urol; 2004 Nov; 172(5 Pt 1):1853-5. PubMed ID: 15540737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
    Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
    BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.